- Telehealth Visits
- Insurance plan information
Aasif Kazi, MD, PharmD
Otolaryngology • Reconstructive Plastic Surgery- Telehealth Visits
- Insurance plan information
Aasif Kazi, MD, PharmD
Otolaryngology • Reconstructive Plastic Surgery- Telehealth Visits
- Insurance plan information
On this page
Education & training
Fellowship
- Head and Neck Oncologic and Reconstructive Surgery, Loma Linda University Hospital Medical Center
- Facial Plastic & Reconstructive, Loma Linda University School of Medicine
Residency
- Otolaryngology, Virginia Commonwealth University GME
- Anesthesiology, Rush University Medical Center GME
Internship
- General Surgery, Rush University Medical Center GME
Degree
- MD, Medical College of Georgia
My expertise
Specialties
Component Name: Provider Research Listing component built but no clinical trials or publications to display
Clinical Trials query: q=health_gateway_id_ss%3A%28%224902%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%224902%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Publication%22
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.